Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.7 USD | -10.00% | -2.17% | -70.84% |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 29.5 | 15.9 | 26.99 | 12.02 | 5.719 | 4.696 | - | - |
Enterprise Value (EV) 1 | 29.5 | 15.9 | 26.99 | 12.02 | 5.719 | 4.696 | 4.696 | 4.696 |
P/E ratio | -2.47 x | -1.24 x | -2.43 x | -0.79 x | -0.01 x | -0.16 x | -0.16 x | -0.17 x |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | - | - | - | - |
EV / Revenue | - | - | - | - | - | - | - | - |
EV / EBITDA | - | - | - | - | - | - | - | - |
EV / FCF | - | - | - | - | - | - | - | - |
FCF Yield | - | - | - | - | - | - | - | - |
Price to Book | - | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 185 | 227 | 358 | 398 | 618 | 1,565 | - | - |
Reference price 2 | 159.8 | 70.00 | 75.40 | 30.20 | 9.260 | 3.000 | 3.000 | 3.000 |
Announcement Date | 05/03/20 | 09/03/21 | 10/03/22 | 30/03/23 | 07/03/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | - | - |
EBIT 1 | -8.693 | -10.91 | -10.44 | -13.9 | -15.84 | -12.88 | -13.52 | -13.72 |
Operating Margin | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -8.599 | -10.88 | -10.44 | -13.87 | -16.08 | -12.82 | -13.44 | -13.56 |
Net income 1 | -8.599 | -10.88 | -10.44 | -13.87 | -16.08 | -12.82 | -13.44 | -13.56 |
Net margin | - | - | - | - | - | - | - | - |
EPS 2 | -64.80 | -56.60 | -31.00 | -38.20 | -672.6 | -18.71 | -18.41 | -17.69 |
Free Cash Flow | - | - | - | - | - | - | - | - |
FCF margin | - | - | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 05/03/20 | 09/03/21 | 10/03/22 | 30/03/23 | 07/03/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBIT 1 | -2.069 | -4.117 | -3.359 | -3.01 | -3.546 | -3.986 | -5.292 | -4.242 | -3.276 | -3.033 | -3.082 | -3.156 | -3.255 | -3.383 |
Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -2.069 | -4.116 | -3.359 | -3.008 | -3.535 | -3.966 | -5.273 | -4.234 | -3.199 | -3.372 | -3.062 | -3.139 | -3.241 | -3.373 |
Net income 1 | -2.069 | -4.116 | -3.359 | -3.008 | -3.535 | -3.966 | -5.273 | -4.234 | -3.199 | -3.372 | -3.062 | -3.139 | -3.241 | -3.373 |
Net margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EPS 2 | -5.800 | -11.80 | -9.400 | -8.400 | -9.800 | -10.60 | -13.20 | -10.60 | -6.400 | -84.60 | -4.540 | -4.600 | -4.710 | -4.850 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 10/11/21 | 10/03/22 | 16/05/22 | 15/08/22 | 14/11/22 | 30/03/23 | 11/05/23 | 14/08/23 | 14/11/23 | 07/03/24 | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex | - | - | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - | - | - |
Announcement Date | 05/03/20 | 09/03/21 | 10/03/22 | 30/03/23 | 07/03/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-70.84% | 4.7M | |
+22.55% | 46.4B | |
-1.56% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+10.13% | 26.01B | |
-20.34% | 19.52B | |
+26.72% | 12.43B | |
+0.03% | 12.18B | |
-0.34% | 12.13B |
- Stock Market
- Equities
- BPTH Stock
- Financials Bio-Path Holdings, Inc.